Related Experiment Video
Updated: Jun 26, 2025

09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
Comparison of three machine learning algorithms for classification of B-cell neoplasms using clinical flow cytometry
Wikum Dinalankara1, David P Ng2, Luigi Marchionni1
1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Cytometry. Part B, Clinical Cytometry
|May 9, 2024
Summary
Artificial intelligence (AI) algorithms can aid in analyzing complex flow cytometry data for disease diagnosis. Two methods, flowCat and EnsembleCNN, showed high accuracy and efficiency in classifying B-cell neoplasms.
Area of Science:
- Clinical diagnostics
- Bioinformatics
- Machine learning in healthcare
Background:
- Multiparameter flow cytometry is crucial for clinical disease diagnosis but is labor-intensive.
- Artificial intelligence (AI) offers potential to automate and improve the interpretation of flow cytometry data.
- Previous studies have explored machine learning for flow cytometry data classification.
Purpose of the Study:
- To evaluate three machine learning methods for classifying flow cytometry data.
- To apply these methods to a B-cell neoplasm dataset for disease subtype prediction.
- To compare algorithm performance based on accuracy and computational time.
Main Methods:
- Examined three established machine learning algorithms for flow cytometry data classification.
- Applied algorithms to ungated flow cytometry data from a B-cell neoplasm cohort.
- Compared algorithm architectures, multiclass classification accuracies, and computation times.
Main Results:
- Two methods, flowCat and EnsembleCNN, achieved comparable high accuracies in classifying B-cell neoplasms.
- Both flowCat and EnsembleCNN demonstrated relatively fast computational performance.
- EnsembleCNN exhibited a speed advantage, especially when incorporating additional training data.
Conclusions:
- AI algorithms, specifically flowCat and EnsembleCNN, show promise in assisting the clinical interpretation of flow cytometry data.
- These AI methods can accurately predict disease subtypes from B-cell neoplasm data.
- EnsembleCNN presents an efficient and scalable solution for flow cytometry data analysis.

